Paxlovid Not on ‘Approved Drug List’ for China’s Health Insurance
China will not include Pfizer Inc’s Paxlovid in an update to its list of medicines covered by basic medical insurance schemes as the U.S. firm quoted a high price for the COVID-19 drug, China’s Healthcare Security Administration (NHSA) said Sunday. The COVID-19 antiviral drug is currently covered by the country’s broad health care insurance scheme…